Clinical Trials Browser

INDUSTRY × Interventional × Radiation Dose Hypofractionation × Clear all

Urogenital Diseases, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT02383212 2020-01-27

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Phase 1 Completed

398 enrolled

Advanced Cancer

Clinical Trials

EV-309

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies